Ruby Del Risco Kollerud1, Lisa A Cannon-Albright2, Hege S Haugnes3,4, Ellen Ruud5,6, Magne Thoresen7, Per Nafstad8, Karl Gerhard Blaasaas9, Øyvind Naess8, Bjørgulf Claussen8. 1. The National Centre for Occupational Rehabilitation, Norway, Norway. 2. Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah. 3. Department of Oncology, University Hospital of North Norway, Tromsø, Norway. 4. Institute of Clinical Medicine, UIT, The Arctic University, Tromsø, Norway. 5. Department of Pediatric Hematology and Oncology, Division for Pediatric- and Adolescence Medicine, Oslo University Hospital, Oslo, Norway. 6. Institute of Clinical Medicine, University of Oslo, Oslo, Norway. 7. Department of Biostatistics, Oslo Centre for Biostatistics and Epidemiology, University of Oslo, Oslo, Norway. 8. Institute of Health and Society, University of Oslo, Oslo, Norway. 9. Finance Norway, Oslo, Norway.
Abstract
BACKGROUND: In this study, we aimed to evaluate incidence rates and family risk of the most common childhood cancers, tumors in the central nervous system (CNS), and leukemia among individuals from Norway and individuals with Scandinavian ancestry living in Utah. METHODS: We used the Utah Population Database and the Norwegian National Population Register linked to Cancer registries to identify cancers in children born between 1966 and 2015 and their first-degree relatives. We calculated incidence rates and hazards ratios. RESULTS: The overall incidence of CNS tumors increased with consecutive birth cohorts similarly in Utah and Norway (both P < 0.001). Incidence rates of leukemia were more stable and similar in both Utah and in Norway with 4.6/100 000 person-years among children (<15 years) born in the last cohort. A family history of CNS tumors was significantly associated with risk of childhood CNS tumors in Utah HR = 3.05 (95% CI 1.80-5.16) and Norway HR = 2.87 (95% CI 2.20-3.74). In Norway, children with a first-degree relative diagnosed with leukemia had high risk of leukemia (HR = 2.39, 95% CI 1.61-3.55). CONCLUSION: Despite geographical distance and assumed large lifestyle differences, two genetically linked pediatric populations show similar incidences of CNS tumors and leukemia in the period 1966-2015. CNS tumors and leukemia aggregated in families in both countries.
BACKGROUND: In this study, we aimed to evaluate incidence rates and family risk of the most common childhood cancers, tumors in the central nervous system (CNS), and leukemia among individuals from Norway and individuals with Scandinavian ancestry living in Utah. METHODS: We used the Utah Population Database and the Norwegian National Population Register linked to Cancer registries to identify cancers in children born between 1966 and 2015 and their first-degree relatives. We calculated incidence rates and hazards ratios. RESULTS: The overall incidence of CNS tumors increased with consecutive birth cohorts similarly in Utah and Norway (both P < 0.001). Incidence rates of leukemia were more stable and similar in both Utah and in Norway with 4.6/100 000 person-years among children (<15 years) born in the last cohort. A family history of CNS tumors was significantly associated with risk of childhood CNS tumors in Utah HR = 3.05 (95% CI 1.80-5.16) and Norway HR = 2.87 (95% CI 2.20-3.74). In Norway, children with a first-degree relative diagnosed with leukemia had high risk of leukemia (HR = 2.39, 95% CI 1.61-3.55). CONCLUSION: Despite geographical distance and assumed large lifestyle differences, two genetically linked pediatric populations show similar incidences of CNS tumors and leukemia in the period 1966-2015. CNS tumors and leukemia aggregated in families in both countries.
Authors: Jessica L Barrington-Trimis; Myles Cockburn; Catherine Metayer; W James Gauderman; Joseph Wiemels; Roberta McKean-Cowdin Journal: Int J Cancer Date: 2016-11-30 Impact factor: 7.396
Authors: Rachel E Neale; Charles A Stiller; Kathryn J Bunch; Elizabeth Milne; Geraldine P Mineau; Michael F G Murphy Journal: Int J Cancer Date: 2013-06-29 Impact factor: 7.396
Authors: O Raaschou-Nielsen; M Sørensen; H Carstensen; T Jensen; T Bernhardtsen; F Gjerris; K Schmiegelow Journal: Br J Cancer Date: 2006-07-25 Impact factor: 7.640
Authors: Eva Steliarova-Foucher; Murielle Colombet; Lynn A G Ries; Florencia Moreno; Anastasia Dolya; Freddie Bray; Peter Hesseling; Hee Young Shin; Charles A Stiller Journal: Lancet Oncol Date: 2017-04-11 Impact factor: 41.316
Authors: David A Siegel; Jun Li; S Jane Henley; Reda J Wilson; Natasha Buchanan Lunsford; Eric Tai; Elizabeth A Van Dyne Journal: MMWR Morb Mortal Wkly Rep Date: 2018-06-29 Impact factor: 17.586